KarkiSDMasoodGRCombination risperidone and SSRI-induced serotonin syndrome. Ann Pharmacother2003;37:388–91.
2.
IsbisterGKDawsonAWhtyeIMComment: serotonin syndrome and 5-HT2A antagonism (letter). Ann Pharmacother2001;35:1143–4.
3.
SternbachH. The serotonin syndrome. Am J Psychiatry1991;148:705–13.
4.
DarmaniNAAhmadBLong-term sequential determination of behavioral ontogeny of 5-HT1A and 5-HT2 receptor functions in the rat. J Pharmacol Exp Ther1999;288:247–53.
5.
HealDJLuscombeG PMartinKF. Pharmacological identification of 5-HT receptor subtypes using behavioural models. In: MarsdenCAHealDJ, eds. Central serotonin receptors and psychotropic drugs. London: Blackwell Scientific Publications, 1992:56–99.
6.
NisijimaKYoshinoTIshiguroTRisperidone counteracts lethality in an animal model of the serotonin syndrome. Psychopharmacology (Berl)2000;150:9–14.
7.
NeuvonenPJPohjola-SintonenSTackeUVuoriEFive fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses. Lancet1993;342:1419.
8.
WhyteIMDawsonAHBuckleyNARelative toxicity of venlafaxine and serotonin specific reuptake inhibitors in overdose compared to tricyclic antidepressants. Q J Med2003;96:369–74.
9.
GraudinsADowsettRPLiddleCThe toxicity of antidepressant poisoning: is it changing?A comparative study of cyclic and newer serotonin-specific antidepressants. Emerg Med (Fremantle)2002;14:440–6.
10.
IsbisterGKDownesFWhyteIM. Olanzapine and serotonin toxicity. Psychiatry Clin Neurosci2003;57:241–2.